Actinium reported data from the Phase III SIERRA trial of Iomab-B for relapsed or refractory acute myeloid leukaemia (r/r AML ...

Summit Therapeutics and Akeso published results for the Phase III HARMONi-2 trial, which tested ivonescimab, a bispecific ...

The trial compares Eli Lilly’s lutetium zadavotide guraxetan with Astellas’s Xtandi or Janssen’s Zytiga for mPRPC.

The blinded blood pressure monitor and scale allows blind data monitoring, where participants can take readings but not see ...

Antimicrobial drugs are widely used around the world to treat infections. However, the overuse of antimicrobials has resulted ...

At the Clinical Trial Supply West Coast 2024 conference, serial biotech entrepreneur Umar Hayat said science should be ...

Merit Medical has revealed positive six-month data from a trial investigating its endoprosthesis in dialysis patients who ...

The patients in the trial had previously undergone endocrine-based therapy and at least one other systemic therapy. Credit: Maria Sbytova / Shutterstock. AstraZeneca and Daiichi Sankyo have reported ...

Novo Nordisk will be initiating a Phase IIb trial of monlunabant to answer some questions about the drug before initiating a pivotal study. Image credit: Shutterstock / Kittyfly. Questions remain over ...

Patritumab deruxtecan’s safety profile in the trial was in line with previous lung cancer studies. Credit: Jo Panuwat D/Shutterstock. Daiichi Sankyo and MSD (Merck & Co) have reported that the Phase ...

Starton is planning larger Phase II trials for chronic lymphocytic leukaemia (CLL) and multiple myeloma in 2025. Credit: Ground Picture via Shutterstock. Starton Therapeutics has successfully ...

The new findings from the NATALEE trial indicate a consistent invasive disease-free survival benefit. Credit: myboys.me / Shutterstock. Novartis has reported a 28.5% reduced risk of breast cancer ...